# OnCo record slc6a2 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/slc6a2/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "slc6a2" ;
  schema:name "SLC6A2"@en ;
  schema:alternateName "solute carrier family 6 member 2"@en, "Sodium-dependent noradrenaline transporter"@en, "NET1"@en, "NAT1"@en, "SLC6A5"@en, "SLC6A2" ;
  schema:description "SLC6A2 (Sodium-dependent noradrenaline transporter) is a gene. The public catalogues list it as a drug target, and an approved or late-stage drug is recorded against it. Tied to Neuroendocrine tumours."@en ;
  schema:url <https://onco.cc/targets/slc6a2/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:11048>, <https://www.uniprot.org/uniprotkb/P23975/entry>, <https://www.ncbi.nlm.nih.gov/gene/6530>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103546> ;
  onco:tag "cancer-genes-wave" ;
  onco:targetClass "other" ;
  schema:sameAs <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:11048>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103546>, <https://www.uniprot.org/uniprotkb/P23975/entry>, <https://www.ncbi.nlm.nih.gov/gene/6530> ;
  onco:related <https://onco.cc/collections/open-targets/> ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/> .